Table 3

HR of PCI versus CABG on clinical outcomes in the proximal LAD and the non-proximal LAD group

EndpointsProximal LADNon-proximal LADP value for interaction
nHR (95% CI)P valuenHR (95% CI)P value
All-cause death at 10 years136/5591.39 (0.99 to 1.95)0.055127/5291.47 (1.03 to 2.09)0.0350.837
All-cause death at maximum follow-up170/5591.36 (1.01 to 1.84)0.044160/5291.35 (0.98 to 1.84)0.0630.955
MACCE at 5 years164/5591.86 (1.36 to 2.55)<0.001159/5291.54 (1.11 to 2.12)0.0090.408
 All-cause death at 5 years63/5591.74 (1.04 to 2.89)0.03361/5291.57 (0.93 to 2.64)0.0930.780
 Cardiac death at 5 years33/5593.96 (1.72 to 9.13)0.00135/5291.50 (0.76 to 2.98)0.2460.078
 MI at 5 years35/5596.52 (2.53 to 16.81)<0.00137/5291.90 (0.95 to 3.78)0.0680.038
 Stroke at 5 years18/5590.53 (0.20 to 1.40)0.19914/5291.59 (0.53 to 4.76)0.4030.136
 Revascularisation at 5 years93/5592.46 (1.59 to 3.79)<0.00197/5291.99 (1.30 to 3.06)0.0020.501
  • HRs are calculated with the ratios of the PCI arm compared with the CABG arm.

  • ‘n’ refers to the number of patients having events/total number of patients in the model.

  • P values highlighted in bold suggest statistical significance (p<0.05).

  • CABG, coronary artery bypass grafting; LAD, left anterior descending artery; MACCE, major adverse cardiac or cerebrovascular event; MI, myocardial infarction; PCI, percutaneous coronary intervention.